Literature DB >> 25161378

Dosage uniformity problems which occur due to technological errors in extemporaneously prepared suppositories in hospitals and pharmacies.

Eva Kalmár1, Jason Richard Lasher2, Thomas Dean Tarry2, Andrea Myers2, Gerda Szakonyi1, György Dombi1, Gabriella Baki2, Kenneth S Alexander2.   

Abstract

The availability of suppositories in Hungary, especially in clinical pharmacy practice, is usually provided by extemporaneous preparations. Due to the known advantages of rectal drug administration, its benefits are frequently utilized in pediatrics. However, errors during the extemporaneous manufacturing process can lead to non-homogenous drug distribution within the dosage units. To determine the root cause of these errors and provide corrective actions, we studied suppository samples prepared with exactly known errors using both cerimetric titration and HPLC technique. Our results show that the most frequent technological error occurs when the pharmacist fails to use the correct displacement factor in the calculations which could lead to a 4.6% increase/decrease in the assay in individual dosage units. The second most important source of error can occur when the molding excess is calculated solely for the suppository base. This can further dilute the final suppository drug concentration causing the assay to be as low as 80%. As a conclusion we emphasize that the application of predetermined displacement factors in calculations for the formulation of suppositories is highly important, which enables the pharmacist to produce a final product containing exactly the determined dose of an active substance despite the different densities of the components.

Keywords:  Cerimetric titration; Clinical pharmacy practice; HPLC; Quality control; Rectal administration

Year:  2013        PMID: 25161378      PMCID: PMC4142357          DOI: 10.1016/j.jsps.2013.07.004

Source DB:  PubMed          Journal:  Saudi Pharm J        ISSN: 1319-0164            Impact factor:   4.330


  9 in total

1.  Usefulness of the preoperative administration of tegafur suppositories as alternative adjuvant chemotherapy for patients with resectable stage II or III colorectal cancer: a KODK4 multicenter randomized control trial.

Authors:  Koji Okabayashi; Hirotoshi Hasegawa; Masahiko Watanabe; Takashi Ohishi; Akio Hisa; Yuko Kitagawa
Journal:  Oncology       Date:  2012-06-21       Impact factor: 2.935

2.  Rectal paracetamol in newborn infants after assisted vaginal delivery may increase pain response.

Authors:  Eva Maria Tinner; Irene Hoesli; Kerstin Jost; Nina Schöbi; Yvonne Ulrich Megged; Tilo Burkhardt; Alexander Krafft; Hans Ulrich Bucher; Daniel Surbek; Mathias Nelle; Christoph Bührer
Journal:  J Pediatr       Date:  2012-07-17       Impact factor: 4.406

3.  Rectal suppository: commonsense and mode of insertion.

Authors:  K H Abd-el-Maeboud; T el-Naggar; E M el-Hawi; S A Mahmoud; S Abd-el-Hay
Journal:  Lancet       Date:  1991-09-28       Impact factor: 79.321

4.  No effect of preoperative paracetamol and codeine suppositories for pain after termination of pregnancies in general anaesthesia.

Authors:  V Dahl; F Fjellanger; J C Raeder
Journal:  Eur J Pain       Date:  2000       Impact factor: 3.931

5.  Ondansetron suppository: an effective treatment for the prevention of emetic disorders induced by cisplatin-based chemotherapy. French Ondansetron Study Group.

Authors:  P Fumoleau; M Giovannini; F Rolland; B Votan; J M Paillarse
Journal:  Oral Oncol       Date:  1997-09       Impact factor: 5.337

6.  Comparative clinical trial of artesunate suppositories and oral artesunate in combination with mefloquine in the treatment of children with acute falciparum malaria.

Authors:  A Sabchareon; P Attanath; P Chanthavanich; P Phanuaksook; V Prarinyanupharb; Y Poonpanich; D Mookmanee; P Teja-Isavadharm; D G Heppner; T G Brewer; T Chongsuphajaisiddhi
Journal:  Am J Trop Med Hyg       Date:  1998-01       Impact factor: 2.345

7.  Treatment of new-onset ulcerative colitis and ulcerative proctitis: a retrospective study.

Authors:  J M Richter; S Kushkuley; J A Barrett; G Oster
Journal:  Aliment Pharmacol Ther       Date:  2012-06-12       Impact factor: 8.171

8.  Novel chronotherapeutic rectal aminophylline delivery system for therapy of asthma.

Authors:  Hideo Shiohira; Makiko Fujii; Naoya Koizumi; Masuo Kondoh; Yoshiteru Watanabe
Journal:  Int J Pharm       Date:  2009-06-23       Impact factor: 5.875

9.  Screening paediatric rectal forms of azithromycin as an alternative to oral or injectable treatment.

Authors:  Tina Kauss; Karen Gaudin; Alexandra Gaubert; Boubakar Ba; Serena Tagliaferri; Fawaz Fawaz; Jean-Louis Fabre; Jean-Michel Boiron; Xavier Lafarge; Nicholas J White; Piero L Olliaro; Pascal Millet
Journal:  Int J Pharm       Date:  2012-07-30       Impact factor: 5.875

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.